COVID-19

As UW Health and the University of Wisconsin begin scheduling participants for the AstraZeneca COVID-19 vaccine study, experts and leaders are focused on equity and inclusion to ensure a diverse population takes part in this phase 3 clinical trial. A diverse group of participants will give researchers the best understanding on how and if this vaccine works for everyone....

The following webinar, presented via a collaboration between the Foundation for Black Women's Wellness, the UW-Madison Collaborative Center for Health Equity, and the 'All of Us' Research Program at UW-Madison, highlights the importance of African American communities' participation in health research....

Our country needs a new path forward in the battle against COVID-19 Wisconsin's two medical schools are heading up this fight by launching innovative clinical trials, developing rapid diagnostic testing, studying the complexities of this virus and increasing our capacity to offer telehealth and virtual visits. Our health care professionals are working tirelessly. But these frontline fighters need support from everyone to limit the spread of this virus....

While the federal government has spent billions in an unprecedented effort to fast-track a vaccine that could be approved in just a few months, the rollout will be fraught with moral, ethical and political issues. Who gets it first? Who wants it? And who doesn’t? In this Q&A, UW-Madison's Dr. Jonathan Temte discusses these issues and more....

Much of the study on the immune response to SARS-CoV-2, the novel coronavirus that causes COVID-19, has focused on the production of antibodies. But, in fact, immune cells known as memory T cells also play an important role in the ability of our immune systems to protect us against many viral infections, including—it now appears—COVID-19....